ABSTRACT
The advances in diabetes care we see today are the product of years of technological advances in glucose measurement and insulin replacement coupled with a fundamental shift in the model of care-from provider-directed to self-management by the patient. The major obstacle to the normalization of glucose levels in type 1 diabetes continues to be the physiologic replacement of insulin. Chapter 5 in this book will discuss the latest strategies for insulin therapy.
